Abbott
Abbott tallies E.U. win for next-gen intraocular lenses
Abbott aims to expand Xience Prime patent for 1.7 years
Medtronic, Johnson & Johnson store billions in cash in overseas subsidiaries | Medtech Wall Street news for the week of June 9, 2014
Medtronic, Johnson & Johnson park billions in offshore accounts
There are no awards handed out for companies with the most money housed in overseas accounts, but keeping cash in tax havens is its own reward for at least a dozen top medical device makers, according to a new study.
Animals in labs: PETA’s long history with the medtech industry
Animal rights activists have long raised concerns about some of the largest medical device companies, taking up minuscule stock holdings to gain access to shareholder meetings at a raft of medtech makers.
Medicare proposes to cover Abbott’s MitraClip heart valve repair device
Medicare today proposed to cover surgeries to fix or replace leaky heart valves called transcatheter mitral valve procedures, issuing a draft National Coverage Decision for the procedure.